Editorial: Advances in the treatment of primary central nervous system lymphoma.
作者信息
Qian Liren, Chavez Julio C, Prakash Gaurav
机构信息
Senior Department of Hematology, The Fifth Medical Center of PLA General Hospital, Beijing, China.
Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, United States.
出版信息
Front Oncol. 2023 Aug 14;13:1271566. doi: 10.3389/fonc.2023.1271566. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Advances in the treatment of primary central nervous system lymphoma.社论：原发性中枢神经系统淋巴瘤的治疗进展
Front Oncol. 2023 Aug 14;13:1271566. doi: 10.3389/fonc.2023.1271566. eCollection 2023.
2
CD79B Y196 mutation is a potent predictive marker for favorable response to R-MPV in primary central nervous system lymphoma.CD79B Y196 突变是原发性中枢神经系统淋巴瘤对 R-MPV 治疗有良好反应的有力预测标志物。
Cancer Med. 2023 Mar;12(6):7116-7126. doi: 10.1002/cam4.5512. Epub 2022 Dec 7.
3
Recent advances in the management of primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤治疗的最新进展
Blood Res. 2020 Jul 31;55(S1):S58-S62. doi: 10.5045/br.2020.S010.
4
Current and emerging therapies for primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤的现有及新兴疗法。
Biomark Res. 2021 May 6;9(1):32. doi: 10.1186/s40364-021-00282-z.
5
[Molecular pathogenesis and therapeutic development of primary central nervous system lymphoma: update and future perspectives].原发性中枢神经系统淋巴瘤的分子发病机制与治疗进展：最新进展与未来展望
Rinsho Ketsueki. 2022;63(9):1145-1156. doi: 10.11406/rinketsu.63.1145.
6
Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas.CD79B和MYD88的复发性突变是原发性中枢神经系统淋巴瘤的标志。
Neuropathol Appl Neurobiol. 2016 Apr;42(3):279-90. doi: 10.1111/nan.12259. Epub 2015 Jul 20.
7
Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?靶向CD19的嵌合抗原受体T细胞疗法是对抗中枢神经系统淋巴瘤的明智策略吗？
Front Oncol. 2023 Jan 5;12:1082235. doi: 10.3389/fonc.2022.1082235. eCollection 2022.
8
Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy.原发性中枢神经系统淋巴瘤患者脑内活检前血游离 DNA 中驱动基因突变热点分析。
J Mol Diagn. 2020 Oct;22(10):1300-1307. doi: 10.1016/j.jmoldx.2020.07.002. Epub 2020 Aug 1.
9
High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma--a randomized phase III trial (MATRix).高剂量化疗和自体干细胞移植与传统化疗用于新诊断的原发性中枢神经系统淋巴瘤巩固治疗的比较——一项随机III期试验（MATRix）
BMC Cancer. 2016 Apr 21;16:282. doi: 10.1186/s12885-016-2311-4.
10
Outcomes of Autologous Stem Cell Transplantation as a Consolidative Strategy for the Treatment of Primary and Isolated Secondary Central Nervous System Diffuse Large B Cell Lymphomas.自体干细胞移植作为原发性和孤立性中枢神经系统弥漫性大 B 细胞淋巴瘤治疗的巩固策略的结果。
Clin Lymphoma Myeloma Leuk. 2023 Jan;23(1):e1-e13. doi: 10.1016/j.clml.2022.09.006. Epub 2022 Oct 9.
本文引用的文献
1
Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL).将LymphGen分类工具应用于928例经临床和基因特征分析的弥漫性大B细胞淋巴瘤（DLBCL）病例。
Br J Haematol. 2021 Jan;192(1):216-220. doi: 10.1111/bjh.17132. Epub 2020 Oct 3.
2
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.具有治疗意义的弥漫性大 B 细胞淋巴瘤遗传亚型的概率分类工具。
Cancer Cell. 2020 Apr 13;37(4):551-568.e14. doi: 10.1016/j.ccell.2020.03.015.
3
Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report.弥漫性大 B 细胞淋巴瘤的靶向测序、分子亚型与结局：血液系统恶性肿瘤研究网络报告
Blood. 2020 May 14;135(20):1759-1771. doi: 10.1182/blood.2019003535.
4
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.弥漫性大 B 细胞淋巴瘤的分子亚型与不同的发病机制和预后相关。
Nat Med. 2018 May;24(5):679-690. doi: 10.1038/s41591-018-0016-8. Epub 2018 Apr 30.
5
Neoplasms of the reticuloendothelial system of the brain.脑网状内皮系统肿瘤
Cancer. 1963 Mar;16:289-305. doi: 10.1002/1097-0142(196303)16:3<289::aid-cncr2820160304>3.0.co;2-z.
6
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.利用分子谱分析预测弥漫性大B细胞淋巴瘤化疗后的生存率。
N Engl J Med. 2002 Jun 20;346(25):1937-47. doi: 10.1056/NEJMoa012914.
7
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.通过基因表达谱鉴定出的不同类型弥漫性大B细胞淋巴瘤。
Nature. 2000 Feb 3;403(6769):503-11. doi: 10.1038/35000501.
8
Primary malignant lymphomas of the central nervous system.中枢神经系统原发性恶性淋巴瘤
Cancer. 1974 Oct;34(4):1293-302. doi: 10.1002/1097-0142(197410)34:4<1293::aid-cncr2820340441>3.0.co;2-p.
Zotero 插件